SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Samsung, SK Hynix to Unveil Record AI and Semiconductor Investment Plans Worth Over $646 Billion 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Ryan Cohen Rejects GameStop Pay Package, Prepares New eBay Acquisition Plan 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines 
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow 
Chick-fil-A Inc., an American restaurant chain specializing in chicken sandwiches, announced it will no longer serve chicken that is antibiotic-free. This decision reversed the brand's long-time pledge of "No Antibiotics Ever."
Why Chick-fil-A Changed Its Stance
According to Associated Press News, Chick-fil-A's move was prompted by the predicted supply shortage. This is also a sudden change of heart from its vow not to use chicken fed with antibiotics.
For years, Chick-fil-A has committed to serving only antibiotic-free chickens. The chain explained that this pledge is intended to help prevent human antibiotic resistance related to the widespread use of the drugs in most livestock production.
A Shift to Standard NAIHM
The restaurant announced it would now embrace a standard called the "no antibiotics important to human medicine" (NAIHM), which means it would allow some antibiotics. The NAIHM involves steering clear of certain medications that are commonly used for the treatment of humans and restricting the usage of animal antibiotics to particular instances of animal illness.
Chick-fil-A shared that it will apply the new NAIHM policy starting this spring. Through its spokesperson, the company said this move mirrors its concerns about its capability to obtain enough supplies of antibiotic-free chicken.
"To maintain supply of the high-quality chicken you expect from us, Chick-fil-A will shift from No Antibiotics Ever (NAE) to No Antibiotics Important To Human Medicine (NAIHM) starting in the Spring of 2024," Chick-fil-A said in a statement.
The fast-food chain added, "NAE means no antibiotics of any kind were used in raising the animal. NAIHM restricts the use of those antibiotics that are important to human medicine and commonly used to treat people, and allows the use of animal antibiotics only if the animal and those around it were to become sick."
Photo by: Malhar Patel/Unsplash
